Skip to main content
. 2017 Nov 14;2017:5812817. doi: 10.1155/2017/5812817

Table 4.

Factors associated with the clinical outcome.

Variable Treatment outcome Crude OR [95% CI] Adjusted OR [95% CI]
Improved (125; 57.6%) Unimproved (92; 42.4%)
Sex
 Male 83 (38.25) 39 (17.97) 1 1
 Female 42 (19.35) 53 (24.42) 2.686 [1.541–4.681]∗∗ 2.919 [1.527–5.279]∗∗
Residence
 Urban 74 (34.01) 51 (23.51) 1 1
 Rural 51 (23.50) 41 (18.89) 1.166 [0.677–2.010] 0.812 [0.380–1.734]
Disease duration
 Less than two years 41 (18.89) 51 (23.50) 1 1
 More than two years 84 (15.47) 41 (18.89) 0.392 [0.225–1.684] 0.249 [0.122–1.508]
Distance
 <2 hours 94 (43.32) 59 (27.19) 1 1
 ≥2 hours 31 (14.29) 33 (15.21) 1.333 [0.49–2.686] 1.367 [0.603–3.099]
Other psychiatric illnesses
 Yes 68 (43.31) 57 (26.26) 1 1
 No 57 (26.26) 35 (16.13) 1.365 [0.789–2.363] 0.824 [0.414–1.642]
Naranjo score
 Possible 10 (4.60) 9 (4.15) 1 Ref
 Probable 91 (41.93) 77 (35.48) 0.940 [0.363–2.432] 0.898 [0.303–2.669]
Level of adherence
 Optimal 62 (28.57) 31 (14.28) 0.37 [0.110–5.379] 0.432 [0.201–0.909]
 Suboptimal 63 (29.03) 61 (28.11) 1 1
Severity of ADR
 Moderate 86 (39.63) 64 (29.49) 1 1
 Sever 14 (6.45) 22 (10.14) 2.112 [1.003–4.444] 2.133 [0.912–4.990]

Statistically significant at 0.05. ∗∗Significant at 0.01.